New Study Reveals Complexity of Long COVID Recovery with Innovative App Tracking
A recent Northwestern University study has shed light on the challenges faced by long COVID patients, revealing that even those who experience improvements still suffer from fluctuating symptoms that significantly impact their quality of life. The research, published in BMC Neurology, used a mobile app to track the recovery patterns of 63 patients over a three-month period.
According to Dr. Igor J. Koralnik, chief of neuroinfectious diseases and global neurology at Northwestern Medicine, the study aimed to better understand the recovery process for long COVID patients who do not fully recover from their symptoms. "The first question patients ask us when they come to the clinic is, 'When am I finally going to improve?'" Dr. Koralnik said. "Some patients have symptoms lasting for years, and that's why we started this study."
The researchers found that while 43% of participants showed measurable improvement over the three-month period, the remaining 57% reported no improvement. Furthermore, those who did experience improvements were characterized by greater variability in their symptoms, including days when they felt better and others when they felt worse.
Interestingly, women were less likely than men to show significant improvements, while participants with changes to their sense of smell and taste were also less likely to benefit from the app. However, those who improved tended to perform better on cognitive tests and reported fewer sleep disturbances compared to those who did not improve.
The study's findings have significant implications for the treatment and management of long COVID patients. Dr. Koralnik emphasized that addressing cognitive function and improving sleep could be key to recovery, stating, "We can create other apps for other chronic diseases and empower patients on their often bumpy road to recovery."
The app used in the study is being expanded to a larger study following patients for a one-year period, with the goal of understanding the root cause of long COVID and developing more effective treatments. As Dr. Koralnik noted, "We hope that this larger study will tell researchers more about the root cause of long COVID and how we can better manage patients and treat their symptoms."
For those living with long COVID, like 27-year-old Grace Huffman-Gottschling, the app provided a valuable tool for tracking symptoms and monitoring progress. Despite her own struggles, she reported that the app was easy to use and encouraged her to categorize her daily symptoms.
However, despite advances in technology, life with long COVID remains challenging, particularly when it comes to social interactions. As Dr. Koralnik acknowledged, "It's really hard to work and be out." The study highlights the need for continued research into the complexities of long COVID and innovative solutions like symptom-tracking apps that can empower patients on their journey to recovery.
The success of this app could indicate a broader opportunity to create similar symptom trackers for other chronic conditions, ultimately improving patient outcomes and quality of life. As Dr. Koralnik said, "We can create other apps for other chronic diseases and empower patients on their often bumpy road to recovery."
A recent Northwestern University study has shed light on the challenges faced by long COVID patients, revealing that even those who experience improvements still suffer from fluctuating symptoms that significantly impact their quality of life. The research, published in BMC Neurology, used a mobile app to track the recovery patterns of 63 patients over a three-month period.
According to Dr. Igor J. Koralnik, chief of neuroinfectious diseases and global neurology at Northwestern Medicine, the study aimed to better understand the recovery process for long COVID patients who do not fully recover from their symptoms. "The first question patients ask us when they come to the clinic is, 'When am I finally going to improve?'" Dr. Koralnik said. "Some patients have symptoms lasting for years, and that's why we started this study."
The researchers found that while 43% of participants showed measurable improvement over the three-month period, the remaining 57% reported no improvement. Furthermore, those who did experience improvements were characterized by greater variability in their symptoms, including days when they felt better and others when they felt worse.
Interestingly, women were less likely than men to show significant improvements, while participants with changes to their sense of smell and taste were also less likely to benefit from the app. However, those who improved tended to perform better on cognitive tests and reported fewer sleep disturbances compared to those who did not improve.
The study's findings have significant implications for the treatment and management of long COVID patients. Dr. Koralnik emphasized that addressing cognitive function and improving sleep could be key to recovery, stating, "We can create other apps for other chronic diseases and empower patients on their often bumpy road to recovery."
The app used in the study is being expanded to a larger study following patients for a one-year period, with the goal of understanding the root cause of long COVID and developing more effective treatments. As Dr. Koralnik noted, "We hope that this larger study will tell researchers more about the root cause of long COVID and how we can better manage patients and treat their symptoms."
For those living with long COVID, like 27-year-old Grace Huffman-Gottschling, the app provided a valuable tool for tracking symptoms and monitoring progress. Despite her own struggles, she reported that the app was easy to use and encouraged her to categorize her daily symptoms.
However, despite advances in technology, life with long COVID remains challenging, particularly when it comes to social interactions. As Dr. Koralnik acknowledged, "It's really hard to work and be out." The study highlights the need for continued research into the complexities of long COVID and innovative solutions like symptom-tracking apps that can empower patients on their journey to recovery.
The success of this app could indicate a broader opportunity to create similar symptom trackers for other chronic conditions, ultimately improving patient outcomes and quality of life. As Dr. Koralnik said, "We can create other apps for other chronic diseases and empower patients on their often bumpy road to recovery."